• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒马曲坦治疗前后偏头痛间歇期与发作期关联性负变的比较。

Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.

作者信息

Göbel H, Krapat S, Ensink F B, Soyka D

机构信息

Department of Neurology, University of Kiel, Germany.

出版信息

Headache. 1993 Nov-Dec;33(10):570-2. doi: 10.1111/j.1526-4610.1993.hed3310570.x.

DOI:10.1111/j.1526-4610.1993.hed3310570.x
PMID:8294198
Abstract

We compared in a placebo controlled, double blind, crossover within-subject design, the amplitude and area integral of contingent negative variation (CNV) using a 2 second interstimulus interval in migraine patients between attack and interval before and after treatment. The study was conducted on 14 female subjects suffering from migraine without aura. The measurements were performed in a balanced sequence at four different times on each patient, twice during the migraine interval and once in each of two migraine attacks. The CNV in the patients was measured first (baseline), then medication was administered on a double-blind basis with an autoinjector, using either 6 mg sumatriptan or a placebo solution. Thirty minutes after administration the CNV parameters were measured again and the changes between pre- and post-treatment were taken as dependent variables. CNV amplitude baseline readings did not differ significantly between the four conditions. Neither administration of placebo nor sumatriptan led to a significant change in CNV parameters independent of whether significant clinical improvement of migraine headache occurred or not. According to our findings CNV-mechanisms between attack and interval are not subject to short-term changes, even though a small, not significant tendency towards a decrease in CNV amplitude during migraine attacks appears to exist. Therefore, it can be assumed that changes in the systems which are depicted by CNV readings are not involved in initiating and terminating acute migraine attacks.

摘要

我们采用安慰剂对照、双盲、受试者内交叉设计,比较了偏头痛患者发作期与发作间期以及治疗前后,在2秒刺激间隔下的关联性负变(CNV)的幅度和面积积分。该研究对14名无先兆偏头痛女性受试者进行。测量在每个患者的四个不同时间以平衡顺序进行,在偏头痛间期进行两次,在两次偏头痛发作中各进行一次。首先测量患者的CNV(基线),然后使用自动注射器以双盲方式给药,使用6毫克舒马曲坦或安慰剂溶液。给药30分钟后再次测量CNV参数,并将治疗前后的变化作为因变量。在四种情况下,CNV幅度的基线读数无显著差异。无论偏头痛头痛是否有显著临床改善,给予安慰剂或舒马曲坦均未导致CNV参数发生显著变化。根据我们的研究结果,尽管在偏头痛发作期间CNV幅度似乎有轻微的、不显著的下降趋势,但发作期与发作间期之间的CNV机制不受短期变化影响。因此,可以假设由CNV读数所描绘的系统变化不参与急性偏头痛发作的起始和终止。

相似文献

1
Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.舒马曲坦治疗前后偏头痛间歇期与发作期关联性负变的比较。
Headache. 1993 Nov-Dec;33(10):570-2. doi: 10.1111/j.1526-4610.1993.hed3310570.x.
2
Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan.
Cephalalgia. 1994 Apr;14(2):143-8. doi: 10.1046/j.1468-2982.1994.1402143.x.
3
Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack.偏头痛发作期间及发作间期的关联性负变:发作期间慢皮层电位正常化的证据。
Cephalalgia. 1995 Apr;15(2):123-8; discussion 78-9. doi: 10.1046/j.1468-2982.1995.015002123.x.
4
Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.无先兆偏头痛发作期间的脑血流量及舒马曲坦的作用
Arch Neurol. 1995 Feb;52(2):135-9. doi: 10.1001/archneur.1995.00540260037013.
5
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.两项关于使用舒马曲坦片速崩/速释制剂急性治疗偏头痛时疼痛缓解起效时间的重复随机、双盲、安慰剂对照试验。
Clin Ther. 2005 Apr;27(4):407-17. doi: 10.1016/j.clinthera.2005.04.003.
6
Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.偏头痛发作的急性治疗:与口服舒马曲坦和安慰剂相比,非甾体抗炎药双氯芬酸钾的疗效和安全性。双氯芬酸钾/舒马曲坦偏头痛研究组
Cephalalgia. 1999 May;19(4):232-40. doi: 10.1046/j.1468-2982.1999.019004232.x.
7
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.随机COMPASS研究中AVP - 825呼吸驱动呼气给药系统(舒马曲坦鼻粉)与口服舒马曲坦在多次偏头痛发作中的早期疗效及反应一致性
Headache. 2017 Jun;57(6):862-876. doi: 10.1111/head.13105. Epub 2017 May 11.
8
Interictal and postictal contingent negative variation in migraine without aura.无先兆偏头痛发作间期和发作后期的关联性负变化
Headache. 2001 Jan;41(1):72-8. doi: 10.1046/j.1526-4610.2001.111006072.x.
9
Neurophysiological reactivity before a migraine attack.偏头痛发作前的神经生理反应。
Neurosci Lett. 2006 May 29;400(1-2):121-4. doi: 10.1016/j.neulet.2006.02.019. Epub 2006 Mar 15.
10
A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.一项关于4毫克皮下注射舒马曲坦治疗成人急性偏头痛发作的疗效和耐受性的随机、双盲、安慰剂对照试验。
Clin Ther. 2006 Apr;28(4):517-26. doi: 10.1016/j.clinthera.2006.03.013.

引用本文的文献

1
Unveiling the Role of Contingent Negative Variation (CNV) in Migraine: A Review of Electrophysiological Studies in Adults and Children.揭示关联性负变(CNV)在偏头痛中的作用:成人和儿童电生理研究综述
Biomedicines. 2023 Nov 11;11(11):3030. doi: 10.3390/biomedicines11113030.
2
Does sumatriptan cross the blood-brain barrier in animals and man?舒马曲坦是否能穿过动物和人类的血脑屏障?
J Headache Pain. 2010 Feb;11(1):5-12. doi: 10.1007/s10194-009-0170-y. Epub 2009 Dec 10.
3
[Electrophysiological studies on headache: the contingent negative variation].
[头痛的电生理研究:关联性负变]
Schmerz. 1996 Jun 17;10(3):130-4. doi: 10.1007/s004829600040.
4
Therapy of Migraine Headache in Cancer Patients.
Curr Rev Pain. 1999;3(3):206-213. doi: 10.1007/s11916-999-0015-z.